
OrbiMed
Venture capital firm · Founded 1989
OrbiMed is a global healthcare investment firm investing for over 25 years across the healthcare industry - from early-stage private companies to large multinational corporations, across public and private markets - spanning biopharmaceuticals, medical devices, digital health, diagnostics and healthcare services, with a team of over 150 scientific, medical and investment professionals.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at OrbiMed, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$21B
Latest fund
OrbiMed Private Investments X — over $1.9 billion, announced 2026 (with Asia Partners VI over $1 billion)
Funds
10
Check size
LAST CHECKED NOV 2026
Stages
Seed
Sectors
HealthcareLife Sciences
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
Track record
Misses
Track record
Partners 4
- Jonathan T. Silverstein
Partner
Board seats
No public record - Sven H. Borho
Partner
Board seats
No public record - Carl L. Gordon
Partner
Board seats
No public record - W. Carter Neild
Partner
Board seats
No public record
Reputation 2
No reputation score — basis not established for this firm.
- Dealroom: largest VC firms by AUM
dealroom.net
- Waveup: top healthcare VC firms guide
waveup.com
Contact
Published sources only
Published contact
- Website
- www.orbimed.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with OrbiMed. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — Grouped by disclosed AUM of $21B (AUM-band grouping — full tier basis pending in the catalog). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for OrbiMed — provenance: GlassVC editorial — entered manually
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Reputation
- [2]
FIRM SITE · OrbiMed — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
